Surprisingly, reverse transcription-PCR (RT-PCR) results showed that M/Ms from metastatic brains expressed both MMP3 and MMP9, whereas RFP-B16 tumor cells barely expressed MMP3 but produced low levels of MMP9 (Fig. 5a, upper panel). This evidence concerns the gene MMP9 and neoplasm.